Department of Pharmacology, Physiology, and Neuroscience, Rutgers University-New Jersey Medical School, Newark, New Jersey 07103, United States.
ACS Infect Dis. 2020 May 8;6(5):916-921. doi: 10.1021/acsinfecdis.9b00473. Epub 2020 Apr 9.
Oxazolidinones are a novel class of antibacterials with excellent activity against resistant Gram-positive bacteria including strains causing multidrug-resistant tuberculosis (TB). Despite their excellent efficacy, optimal dosing strategies to limit their toxicities are still under development. Here, we developed a novel synthetic strategy for fluorine-18-radiolabeled oxazolidinones. As proof-of-concept, we performed whole-body F-linezolid positron emission tomography (PET) in a mouse model of pulmonary TB for noninvasive measurements of time-activity curves in multiple compartments with subsequent confirmation by tissue gamma counting. After intravenous injection, F-linezolid rapidly distributed to all organs with excellent penetration into -infected lungs. Drug biodistribution studies with PET can provide unbiased, drug measurements, which could boost efforts to optimize antibiotic dosing strategies.
噁唑烷酮类是一类新型的抗菌药物,对耐药革兰阳性菌具有极好的活性,包括引起耐多药结核病(TB)的菌株。尽管它们具有极好的疗效,但仍在开发限制其毒性的最佳剂量策略。在这里,我们开发了一种新型的氟-18 放射性标记噁唑烷酮的合成策略。作为概念验证,我们在肺结核小鼠模型中进行了全身 F-利奈唑胺正电子发射断层扫描(PET),以非侵入性方式测量多个隔室中的时间-活性曲线,并通过组织伽马计数进行后续确认。静脉注射后,F-利奈唑胺迅速分布到所有器官,对感染的肺部有极好的穿透性。使用 PET 进行药物生物分布研究可以提供无偏倚的药物测量,这可以促进优化抗生素剂量策略的努力。